INTRODUCTION
The latter half of the 20th century witnessed a veritable genesis for research ethics and policy. Prior to this, little or no formal protections were afforded to the research subject. The Nuremberg trials illustrated how research can be conducted in a completely unethical fashion. 1 These terrible historical events F conducted by a scientifically advanced, but, at its heart a morally bankrupt medical system F resulted in an impetus to strive for not only methodologically perfect research but research that is ethically of the highest quality.
Experience has since shown that this is no easy task: research has so many nuances, specificities, and local concerns that striving for methodological and ethical ''perfection'' is a difficult task. The additional complications incurred by surrogate decision-making for the participation in research by subjects incapable of giving informed consent, seem to make this nearly impossible. The Neonatal Intensive Care Unit (NICU) is one such surrogate decision-making environment that presents unique issues regarding recruitment and the informed consent process. This paper considers current and suggested recruitment models and outlines a proposed systematic approach for the consent process in the NICU setting that can be broadly applied for the majority of NICU solicitation situations. It is argued that following this ethically optimising model will improve the capabilities of parents to make truly informed choices as regards research.
BACKGROUND
Preterm birth (<37 weeks gestation) and admission of an infant to the NICU are well documented to be associated with parental stress, 2-5 distress, 6,7 emotion, 2,4,8 emptiness 5 and powerlessness. 2 Soliciting consent for research from parents may increase parental distress further. 6, 7 Parents commonly experience an inability to comprehend medical jargon and scientific concepts, 2,5,9,10 which may be exacerbated when urgent and difficult decisions 6, 7 are required. Initially following birth, parents are forced to deal with the physical issues associated with preterm delivery and recovery. These issues are often compounded by a stormy antenatal course. 6 At this critical juncture, parents are obliged to assume the responsibility of making decisions for another person 7, 11 requiring that they choose among options based upon personal preference 8 that reflects the child's best interest. For the parent who craves assurance and direction, with no previous experience to draw upon, this can be daunting. Their concern is to try to make the right decision to benefit at least future infants if not their own.
Making a truly informed choice for the participation of an infant in a clinical trial involving a significant intervention requires considerable forethought. But the human response to illness is often less than rational, 7 undermining parental ability to make autonomous informed decisions. Some 6 have argued that reasonable understanding and voluntariness are likely to be so severely compromised at such times that informed consent for emergency neonatal research cannot be obtained. Hewlett 12 contends that the experience of illness, accompanying psychological responses, and the vulnerability of hospitalised patients threaten the voluntariness of clinical research. Just so, it would seem that a parent, in the NICU for the first time, grappling with new concepts, stressed, emotionally fragile, and overcome by powerlessness, would seem an unlikely candidate for authentic consent. These difficulties become more complicated when coupled with language barriers, social, cultural and/or religious issues.
Is it ever ethical to include such vulnerable patients in trials? We assume it is and in this we follow international guidelines that allow such inclusion. But the way in which parents are solicited for consent should be of the utmost concern for all. Many methods of approaching the surrogate decision-making process have been postulated and argued. In this paper, they are referred to as recruitment models and are discussed in the following section.
RECRUITMENT MODELS Standard Consent
The most common and widely used model incorporates the solicitation of parents for a study at the time the infant becomes eligible. Parents are given information both written and verbal, are encouraged to ask questions, and required to sign a consent document in the event they choose to agree to allow their infant to participate. This model, however, is not uniformly embraced by investigators. The standard model is difficult to apply for studies involving emergency procedures as time is of the essence. 6 Investigators are also concerned about decreased parental enrollment due to; invasiveness of research protocols, severity of illness of the infant, lack of benefit for the infant enrolled in the study, and the negative impact of the formal terms used in the written information and consent form. 13 As a result of these reasons, Pierro and Spitz 13 found a 30 to 70% increase in parental declines for studies in their unit leading them to assert that ''clinical research in pediatrics is in danger''. These concerns coupled with the concern about parental ability to make a true informed consent, have prompted investigators to look for alternative methods of recruiting.
Advanced Consent
The advanced consent model attempts to avoid problematic issues regarding the solicitation of consent by approaching parents in advance of their child's eligibility for a study. It incorporates a process whereby parents are approached in anticipation that their infant will meet the inclusion criteria at a later date. It is commonly utilised in the antenatal period for later postnatal enrolment.
14 Criticism of this model focuses on the potential for burdening parents with information that is unnecessary should their infant fail to meet the inclusion criteria. Conflict can also arise when parents are given information about neonatal studies antenatally and at the same time are solicited for maternal studies. Given that requesting consent from parents may increase their distress, 6 ,7 parents should not be subjected to this hazard if there is a good chance their child would not be eligible for the trial. In the case of solicitation for antenatal consent, it is not known that a parent's antenatal stress level is any less than the stress level would be postnatally to warrant early solicitation. Furthermore, since there is no way to know with certainty when the infant will be eligible, parents may fail to recall the specifics of the study or, indeed, ever being approached at all. In instances where research involves the immediate postnatal period, as in the prevention of meconium aspiration, 14 however, antenatal consent is unavoidable. For the majority of studies that occur in the NICU, the advanced consent model should not be applied.
Presumed Consent
The presumed consent model attempts to deal with difficult issues regarding parental stress and decision-making by removing the burden of decision-making from them completely. Suggested for use in the emergency evaluation of new treatments, parents are informed antenatally that the hospital participates in research and that their infant may qualify and be enrolled in a study. 6 Parents are not, however, asked for their explicit consent. Importantly, this model contravenes the law in many jurisdictions. Laws regarding consent and surrogate decision-making may also specify who, if anyone, can consent on an incapable person's behalf to participate in a trial. Most importantly, then, this model overrides parental autonomy 6 by not allowing parents to choose among options. This may become particularly contentious when treatment and experimental options with different risk/benefit ratios require comparison and choice among them.
Moreover, although attempting to minimise postnatal stress, this model may actually exacerbate it by causing parents to worry, 6 perhaps unnecessarily, that their child might be in a trial and they not know it. On the other hand, parents may ignore, forget or fail to pay attention to information that is given to them antenatally and assume it will never affect their infant(s). 6 Another criticism of this model is that it does not respect the individual nature of each family. It assumes all babies, parents and families are similar and should be treated the same. Consenting parents enter into an agreement with a specific investigator who is responsible for a specific project. When utilising the presumed consent model, the parent can make the assumption that the entire unit supports the research that is being done, placing a certain level of responsibility regarding the project on all care-givers and medical professionals who work in that setting.
Randomisation without Consent
Analogous to the presumed consent model, Modi 15 and Truog et al. 16 each presented a model where infants are randomised without parents' consent when comparing two standard methods of 15 The aim of this model focuses on relieving stress and the decision-making burden from parents for treatments that would otherwise be routine practice in a given setting. The specificity of this model make its contribution to solving the problems associated with surrogate decision making in the NICU nominal. The same criticisms may be made of it as of the previous model. Most importantly, it does not respect the parent's rightsenshrined in law in most jurisdictions and not just ethics-to make choices regarding the care of their infant.
Waiver of Consent
In certain specific circumstances Local Research Ethics Committees (LREC, also known as the Research Ethics Board (REB) or Institutional Review Board (IRB)), will waive consent for a study. Usually, this is only done for innocuous studies such as retrospective chart reviews. Waivers of consent, however, are sometimes utilised for studies that require immediate randomisation as in the case of new emergency procedures for resuscitation of patients, and are rarely acceptable in NICU research practice. Wiswell et al. 17 studied the delivery room management of the apparently vigorous meconium-stained neonate, where a rare waiver of consent was applied and granted for recruitment as it satisfied regulations (45 CFR 46.116[d]) 18 that allowed for a waiver of consent, which are; the research involves no more than minimal risk to the subjects; the waiver or alteration will not adversely affect the rights and welfare of the subject; the research could not be practicably carried out without the waiver or alteration; and whenever appropriate, the subjects will be provided with additional pertinent information after participation. Despite this, waiving consent is not broadly applicable.
Committee Consent
Along the same lines of randomising without parental consent is the committee consent model. In this instance the LREC would examine trials on behalf of potential trial patients 2 and would be required to make a decision on behalf of a specific patient that is eligible for a specific study. Can and should LRECs make decisions on a per patient level and is it not burdensome to require already busy LRECs to do so? It is unlikely that any LREC would be able to make decisions for individual patients because they cannot know the specific individualities of each case, baby, family, unit or circumstance, 2 nor is it likely that they would be able to be available around the clock to make these decisions within the necessary timeframe allotted. Furthermore, whether made by committee or individuals, in non-emergency situations deciding for others by health care practitioners is illegal and not compatible with the 21st century ''best-practices'' as regards research.
Opting Out
The opt-out model is similar to the presumed consent model in that parental consent is presumed. It differs, however, because parents may object to their infant's enrolment following a discussion of the study. It is assumed an eligible child will be enrolled in an appropriate protocol unless the parents veto it. Modi 7 presented this model as a way of lessening parental distress caused by soliciting consent. Manning 6 argued that it removes some of the decision-making burden and increases enrolment resulting in the generation of valuable knowledge earlier.
In a study aimed at identifying disability, Mutch and King 19 reported a 97% recruitment rate using the opt-out approach, compared to 79% recruitment rate using the standard opt-in approach. The opt-out method of recruiting, however, may fail to respect parental autonomy in allowing parents to make an unbiased choice. Informing parents of a study that their baby will be enrolled in unless they object, may colour parents' perception of the study. It may seem to them that experimental intervention is ''treatment'' in the unit and that medical staff endorse the study enough such that asking their permission is almost unnecessary.
One other argument in favour of opting-out that has been presented is that opting-out can be less biased than opting-in in instances where risk is not increased by study participation. Rogers et al. 20 state that, ''in our society a signed document is usually required only when extra risk or expense is incurred''. Hence, requiring a parent to sign a consent form for a benign study could be misleading. As compelling as this argument is, it is only applicable in instances where the study involves no perceived risk which is representative of only a small portion of the protocols. Furthermore, risk perception is subjective in nature and requires patient/family input to define.
WEAKNESSES OF THE EXISTING AND PREVIOUSLY PROPOSED MODELS
The most compelling argument opposing the presumed consent, randomisation without consent, committee consent and opt-out models is the expectation of parents that they will be solicited for consent. Singhal et al. 4 surveyed 72 parents (72% response rate) of newborn babies in the NICU, and 166 parents (64% response rate) of normal newborns. In total, 90.1% of NICU parents and 91.1% of parents of normal newborns agreed that, ''all forms of research with babies, no matter how minor, should be carried out only after parents have given informed consent''. Only 7.0% of NICU parents and 3.9% of parents of normal newborns agreed that, ''doctors should make the decisions about which babies should be in research; I do not think the parents should have to make a decision''. Stenson et al. 21 surveyed 154 parents (64% response rate) whose infants had been enrolled in a randomised controlled trial (RCT) during the early neonatal period and reported that 83% of the respondents would be ''unhappy to forgo the consent process for trials passed by the institutional ethics committee''. These data illustrate that parents expect to be asked to allow their child to participate in research and do not feel it should be left to the discretion of physicians.
A great concern for surrogate decision-making in the neonatal setting is the promotion and protection of parental autonomy. How is this dedication to self-determination maintained in instances where parents want more assistance when making decisions? Zupancic et al. 22 surveyed NICU parents to determine what extent parental consent is influenced by risk/benefit deliberation compared to factors like the infant's level of illness at decision making, socio-demographic characteristics and research attitudes. During a 2-year period, 186 parents were solicited for study consent for one of three studies. A total of 167 (convenience sample) of these parents were asked to complete the questionnaire of which 140 (84%) responded. Although the groups (consenters vs non-consenters) were disproportionate (response rate 103:37) a large number of questionnaires from each of the two groups were returned. Of the returns, 103 (83% response rate of consenters) had consented to their infant's participation, and 37 (86% response rate of non-consenters) had declined. A significant multiple correlation was shown for consent decision and risk, benefit and attitudes (r ¼ 0.502, p<0.0001) which suggest that parents are influenced by risk/benefit assessment, attitudes towards research, and the integrity of the consent process when making decision for their infants participation in research. Although the three studies were comparably different, which may have affected parental responses, relevant study results showed 32% of parents who had been solicited for trial consent for their infant(s) wanted their doctor to advise them whether their baby should be enrolled in a study or not.
Singhal et al. 4 surveyed parents of healthy newborns and parents of NICU infants to examine the beliefs of parents regarding; the acceptability of research with babies, the kinds of researchrelated risks that they would be willing to allow their newborns to be subjected to, when they feel they should be solicited for consent, if differences in beliefs exist between parents of sick infants and normal newborns, if differences in beliefs exist between mothers and fathers of newborns infants, and if a relationship exists between the educational achievements of parents and attitudes towards research. The two convenience sampled groups were disproportionate and are summarised in Table 1 . As compared with parents of normal babies, NICU parents more strongly believed that doctors should carry out research with babies (p<0.05), and NICU parents were more likely to enroll their infants in studies of moderate risk that had possible major direct benefit (p ¼ 0.004). Additionally, data showed that 49.3% of NICU and 36.1% of normal newborn parents would consent for research if advised to do so by their infants' doctor.
Zupancic et al.'s 22 study results showing a proportion of parents wanted their doctors to advise them on study enrolment and Singal's 4 results that a large proportion of parents would consent if advised by their doctors, prompt the notion of shared decisionmaking where physicians supply the facts and parents supply the values. 23 Initially shared decision-making seems promising in taking some of the burden from the parent in stressful circumstances and maintaining respect for personal autonomy and family individuality. But shared decision-making implies ownership in part by the physician and/or investigator and as a result partial culpability for the decision, when in reality ''it is the prerogative of the patient, not the physician, to determine where his/her interests seem to lie''. 24 Another potential problem with this model may occur when the physician is also the investigator, creating a conflict of interest in the decision-making process. 25 It would be a challenge for any investigator to be completely unbiased about a study that one has designed. Furthermore, if a decision is made at the advice of the physician and a negative outcome ensues, the physician may be blamed for recommending the choice, creating an atmosphere of blame and mistrust.
Few would dispute the vulnerability of children and their need to be protected. But should parents of critically ill infants not be afforded the same protection? Harth et al. 26 compared psychometric tests of 68 (94.5% participation rate) families who had volunteered their children for a double-blind, placebo-controlled RCT vs 42 (70% participation rate) who had declined, to determine if there were any significant personality differences between parents who volunteer their children for research and those that do not. Although the sample size was based on convenience, and the volunteer group had higher ratio of mothers to fathers (76.5:23.5) compared to the comparison group that had a 50:50 split of mothers to fathers, investigators concluded that the parents who volunteered their children for clinical research were ''socially disadvantaged,yemotionally vulnerable'' and ''psychologically predisposed to volunteering''. They further suggested that, ''it may be necessary to take into consideration the vulnerability not only of children, but also of their parents, in the recruitment of child subjects for clinical research''.
FRAMEWORK FOR AN ALTERNATIVE APPROACH
There is a paucity of literature testing and/or comparing the aforementioned recruitment models in the NICU setting, and it is clear that there are many inadequacies regarding current consenting processes (Table 2) . Even if these models were to be scientifically assessed, each would still fail to be individually applicable to the majority of research solicitation situations in the NICU setting. Of primary importance is the fragile emotional state and vulnerability of parents, which has led some to question whether parents are able to make a true informed consent at all. Thus, there is an impetus to improve the recruitment process given the inadequacies of present models and a need to not only protect but also to promote parental autonomy. As it has been illustrated, parents do not want research decisions regarding their infants left to a third party. Therefore, the enrollment of neonates in studies should begin by utilising a model that requires parents to be asked for permission. The next step in the evolution of the consent process requires that measures be taken to encourage compassion for the vulnerable family while promoting their right, should they wish to exercise it, to self-determination. The likelihood of parents' ability to make a true informed choice may be improved following a systematic approach to consent and recruitment that encourages a respect for parental autonomy as well as compassion for the family within the neonatal setting. Each of the following sections discusses a particular component that is pertinent to the systematic approach and is aided visually via the attached algorithm ( Figure 1 ). It is proposed as a tool to assist investigators approaching the consent process and is applicable to the majority of potential solicitation situations commonly found in the NICU setting. There are, undoubtedly, research protocols for which the tool may not be best applicable, however, these protocols are either innocuous (like chart reviews) or are uncommon.
KEY PRINCIPLES OF THE MORALLY OPTIMISING APPROACH TO RESEARCH RECRUITMENT (i) Parents Ought to be Approached ''One Study at a Time''
The recruitment screening process often finds infants eligible for more than one study at any given time. It is not uncommon that parents are solicited for two or even three studies at once. If parents are unlikely to make a true informed consent for one study, will they be able to make informed consents for more than one study? Proponents might argue that piggybacking study solicitations is acceptable for studies that are similar in nature but do not inhibit each other in any way. While convenient, this style of solicitation may impose a greater burden on the parent. Soliciting two studies at once suggests that the two go together and encourages an all or nothing choice situation. Piggybacking solicitations can benefit a hard to sell study, but it can also backfire and hinder the success of another. In order for a study to be considered thoughtfully and for parental autonomy to be respected, a study should stand alone in its presentation and be deliberated upon individually. Limiting additional information for the parents to process may increase the likelihood of their comprehension regarding the specifics of the study, and the likelihood of a true informed consent.
(ii) Studies Ought to Have Relevance to Current Clinical Status of the Neonate An investigator who approaches a family for a research project for which their infant is not yet eligible (has not met eligibility criteria yet, but is likely to at a future date) asks parents to redirect their focus to something that is not a priority, and may never be relevant. Although it is important to give parents time to deliberate and make an informed choice, parents need not be approached for a study that will not be relevant for days or weeks to come. Additionally, an investigator who prematurely solicits parents for study participation may prevent the success of another study that is relevant to the infants' current clinical status, creating further conflicts among investigators. Situations like these may create an environment of tension for the bedside caregiver who on occasion, find themselves in the midst of investigator battles for recruitment while advocating for the infant and meeting the needs of the parents. Consequently, following the proposed strategy would require that parents only be approached for a research project that is relevant to the infant's current clinical status ( Figure 1A ).
(iii) Researchers Ought to Minimise Information Overload
At the time of an infant's admission, parents are forced to rapidly digest a tremendous amount of new information while coping with the shock and emotion associated with a premature and/or difficult delivery. Time is needed to process information but is frequently unavailable in emergency decision-making situations. Just as in adult medicine, ''patient-centred care'' is in vogue, so, too, in neonatology, ''family-centred care'' 27 is a popular paradigm of choice. This paradigm requires caregivers be committed to the physical, psychological, and cultural ''well-being'' health of the baby within the family unit. Information given to parents may heighten their stress, undermining this well-being. Thus, research solicitation should be considered elective, be guided by parental receptiveness, and must be done in a sensitive, empathic, and culturally appropriate fashion.
(iv) Researchers Ought to Promote Respect for Parental Autonomy Essential to this proposed approach and rationale is the notion of respect for parental autonomy. Part of Immanuel Kant's (1724-1804) Categorical Imperative tells us to ''act in such a way that you always treat humanity, whether in your own person or in the person of any other, never simply as a means, but always at the same time as an end''. 28 In terms of parents in the NICU setting, it is not ethical to simply use parents as a means to achieving the goal of recruiting their infant(s); they (and their child) must be valued them in themselves. Research regarding infants in the critical care setting relates specifically to the infant, yet in order to gain access to an infant one must go through the parent, and the parent is used as a means to an end. The only practical way of valuing parents as means and at the same time an ends in the case of research and the consent process, is to expect that they will be fully informed (should that be their choice) and that their permission to be approached will always be solicited ( Figure 1D,G) . Showing respect for parental autonomy by requesting permission to solicit for research respects parents for their individuality and situational differences, respecting them as ends in themselves.
(v) Researchers Ought to Inform Parents about Research
Obtaining informed choice ought to be a process, not an event, particularly in the NICU. Manning 6 described this notion in reference to the presumed consent model as ''continuing consent,'' requiring regular meetings with parents before, during, and after their infant's involvement in the trial. This concept of continuous consent is supported by the work of Pinch and Spielman. 5 In a qualitative design, a convenience sample of 32 families of NICU infants were interviewed over a period of 12 months prior to discharge to describe perceptions of ethical decision-making. Most relevant to the concept of continuous consent is noted in results regarding the theme of context of decision-making. Study results showed that parents want more scheduled time with health professionals, particularly the physician.
Utilising continuous consent requires that parents be informed about research and their rights, prior to any request for their infant's participation ( Figure 1B,C) . Harth and Thong 29 interviewed 64 parents whose children had been involved in one RCT to determine their perceptions and attitudes about informed consent. Only 45.2% of parents knew that they were able to withdraw their child from the research study at any time. 32.4% believed they were not allowed to withdraw their child, 21% responded that they could withdraw with good reason, and 1.4% were unsure. These results suggest that there is a need for more education regarding research in the NICU setting. The continuous consent process commences before a patient is screened for eligibility, and continues long after the completion of the intervention. 10 Informing parents about research and their rights need not be a long and arduous process. In the rare instances where time is limited and decisions need be made immediately, the continuous consent process becomes even more important as parents are reminded about their rights and the specifics of the study after enrollment and for as long as they require for their satisfaction. A unit that educates parents about research and their rights (including their right to withdraw) prior to solicitation for enrolment, creates an environment of trust and respect that is conducive to quality research.
Following the disclosure of information regarding research ( Figure 1C) , and the determination that the parent is willing to be approached ( Figure 1D ), parents may then be solicited. Following the initial approach for consent and after any subsequent approach, parents should be asked if they are willing to be approached again ( Figure 1G ). In his 2003 keynote address to the Association of Clinical Research Professionals, Arthur Caplan 30 commented that persons who allow themselves to be studied are giving a gift. The continuous process of consent requires that the gift parents give be respected and valued on an ongoing basis. Along with being informed of their rights, parents want to know the results of the studies that their infants were enrolled in. In valuing the parent and the infant by carrying the consent process into the post-study dissemination of information, we are proceeding in a way consistent with the Kantian framework showing respect for the parents and infants as a means and at the same time as ends.
(vi) There Must be Adequate Time to Make Decisions Parents who are forced to make decisions quickly are unlikely to give study information the time it needs for adequate deliberation. In an editorial, Levene 31 reported the results of an unpublished study comparing early vs late consent over an 18-month period for 52 premature infants that were eligible for two RCTs. In Study A, parents were approached before or immediately after birth and required consent within 2 hours of eligibility. Study B sought consent at 6 to 8 days of age and allowed parents a couple of days to decide. Of 42 parents, study A solicited 30 (71.4%) consented to study participation and 16 of 37 (43.2%) consented to study participation for study B. These results prompted investigators to state; ''We believe that ''informed consent'' for an early entry RCT cannot be as complete as consent obtained later. Early consent is not likely to be ''educated consent'' or ''understanding consent'' and we believe this is the principle reason for a higher acceptance rate where consent is obtained early''. Hence, offering parents more time to deliberate and make decisions together is essential for the informed consent process.
Manning 6 referred to at least a 24-hour time period for deliberation required by LRECs for non-urgent research. Research by Loue et al. 32 focusing on differences between Western and Ugandan cultural differences and the need to involve family members, presented workshop participants' recommendations for a 48-hour waiting period between solicitation and decision. Although their work did not pertain to neonates, the importance of respecting cultural influences may be particularly relevant to the multicultural settings of many NICUs. Kuczewski and Marshall 10 also supported the concept of delayed consent to, ''accommodate cultural norms regarding family involvement in the decision making process without diminishing the importance of respect for the individual'', and Bosk 33 suggested a ''cooling-off period'' where options may be evaluated. The importance of the waiting period is even more pronounced when dealing with language issues. Parents whose native language is not that of the center should experience no prejudice in the care of their child, including the right to participate in research. Failing to speak the native language should not result in an automatic ineligibility for studies. A specified waiting period may be essential for the utilisation of additional translators to support comprehension. Barring research done in emergency settings ( Figure 1H ), we would recommend a 48-hour delay between solicitation for research and decision determination.
(vii) There Must be Limits on Subsequent Solicitation Approaches Currently, there exist little data to suggest how parents feel about multiple research approaches and participation of their infants. Anecdotal experience, however, suggests that parents may feel overburdened by repeated approaches for research participation. The establishment of a brief waiting period between solicitation approaches may alleviate information and decision-making pressures, provide some recovery time from a previous approach, minimise the impression of parents being used only as a means to an end, yet still allow the baby to be eligible for further study participation after the waiting period had expired. The NICU at Sunnybrook and Women's College Health Sciences Centre has chosen, after consideration by the multidisciplinary team, an arbitrary waiting period of 48 hours between each parental decision ( Figure 1E ). Additionally at this center, an infant may be enrolled in only one study in the first 72 hours of life ( Figure 1E ). This provision attempts to respect the acute phase immediately after birth in preventing the dissemination of unnecessary information while appreciating that some studies specifically focus on the acute phase. As a result, parents are likely to be approached for studies that require immediate enrolment during this period or in the case where an antenatal consent is required, shortly before delivery. Other projects are encouraged to wait until parents become more accustomed to the NICU environment. It is hoped that ongoing research on this topic will aid in establishing clear practice guidelines.
Finally, parents who are deliberating a study should have the opportunity to do so without being approached for any other study. Accordingly, a decision should be made for a previously solicited study approach before parents are approached again ( Figure 1F ). Parents are constantly receiving and processing information from the bedside nurse, physician, paramedical professionals, family and friends on a daily basis. Soliciting for one study before they have completed the deliberation of another may create confusion and frustration.
(viii) Therapeutic Emergency Research Occasionally, research carried out in the NICU is applicable for situations where there is no other alternative available and may well be the last chance offered to parents to treat a critically ill child. These situations are classified under the heading Therapeutic Emergency Research ( Figure 1H ). In such instances it would be unreasonable to apply certain elements of the model such as: only one study in the first 72 hours of life; waiting 48 hours between approach; or waiting for a decision to be made from a previous approach, when an infants life may be at stake and time is of the essence. Parents are still informed about research and their rights, asked if they wish to be approached for research at all, and then asked for their consent to participate in the study. As a result, their autonomy is preserved, they are not used simply as a mean to an end, and the urgency of decision-making and application of the study manoeuvre is not compromised.
CONCLUSION
The preceding ethically optimising model outlines a stepwise continuous process for obtaining consent for neonatal research in the NICU setting. It incorporates the key principles of; approaching for one study at a time, assuring the study is relevant to the infants' current clinical status, minimising information overload, informing parents about research and their rights prior to any solicitation, asking parents if they wish to be approached for research, allowing parents plenty of time to deliberate (when possible), and providing a waiting period between subsequent approaches. Research regarding parental perceptions of research and multiple study approaches is currently being conducted and will aid in answering questions such as timing of approach and interval between subsequent approaches, which is essential to components of the algorithm. Following this, a comparison study will be required to begin testing the model where parent, investigator, and bedside caregiver satisfaction will be examined.
Baum 34 reiterates an argument that RCT's are ethically impossible because the clinician must be in perfect equipoise regarding either of the two treatments and the patient must be provided perfect information that they understand perfectly and express perfect equipoise themselves. Accepting this position strictly would exclude most if not all human research. We do not live in a perfect world, nor is perfection attainable constantly in research. Objectifying the goal of ethical research, however, forces us to continually question research practice and in doing so, continually improve how it is done. Ubel 8 stated, ''bioethics does not demand that patients make ''good'' or ''rational'' decisions. Instead, the ethical goal of informed consent is to give patients comprehensible information and let them make uncoerced choices. If patients make decisions that others consider to be irrational, that is their right''. In the NICU setting, investigators cannot assure that parents understand every specific of a study. They can, however, approach the process of research in a fashion that respects individuality, promotes understanding and encourages parents to make uncoerced choices. The ability of parents to make a truly informed choice for their infants may be improved by following this proposed systematic approach to create a research environment that treats parents as means and as ends at the same time.
